SEC Form 4 · accession 0001171843-15-000421
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph I Bower
Director
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 26, 2015 | A | 1,275 | $14.33 | A | 31,817 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $14.33 | Jan 26, 2015 | M | 1,275 | D | — | Apr 25, 2015 | Common Stock | 1,275 | 0 | D |
Explanation of responses
- F1Exercise of stock options granted on April 25, 2005 with an expiration date of April 25, 2015.